Detalhe da pesquisa
1.
Antiproliferative, proapoptotic, and tumor-suppressing effects of the novel anticancer agent alsevirone in prostate cancer cells and xenografts.
Arch Pharm (Weinheim)
; 355(1): e2100316, 2022 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-34668210
2.
Oxazolinyl derivatives of androst-16-ene as inhibitors of CYP17A1 activity and prostate carcinoma cells proliferation: Effects of substituents in oxazolinyl moiety.
J Steroid Biochem Mol Biol
; 230: 106280, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36870373
3.
Novel Nitrogen Containing Steroid Derivatives for Prostate Cancer Treatment.
Curr Med Chem
; 28(40): 8416-8432, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33557730
4.
New steroidal oxazolines, benzoxazoles and benzimidazoles related to abiraterone and galeterone.
Steroids
; 153: 108534, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31678134
5.
New azole derivatives of [17(20)E]-21-norpregnene: Synthesis and inhibition of prostate carcinoma cell growth.
Steroids
; 147: 10-18, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-30149075
6.
Comparison of [17(20)E]-21-Norpregnene oxazolinyl and benzoxazolyl derivatives as inhibitors of CYP17A1 activity and prostate carcinoma cells growth.
Steroids
; 129: 24-34, 2018 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29183745
7.
Corrigendum to "Comparison of [17(20)E]-21-Norpregnene oxazolinyl and benzoxazolyl derivatives as inhibitors of CYP17A1 activity and prostate carcinoma cells growth" [Steroids 129 (2018) 24-34].
Steroids
; 136: 93, 2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-29880207